Cargando…
Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity
BACKGROUND: Serological data on endemic human coronaviruses (HCoVs) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in southern Africa are scarce. Here, we report on (1) endemic HCoV seasonality, (2) SARS-CoV-2 seroprevalence, and (3) correlates of SARS-CoV-2 seropositivity and stre...
Autores principales: | Brown, Jennifer A, Hauser, Anthony, Abela, Irene A, Pasin, Chloé, Epp, Selina, Mohloanyane, Tsepang, Nsakala, Bienvenu L, Trkola, Alexandra, Labhardt, Niklaus D, Kouyos, Roger D, Günthard, Huldrych F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582919/ https://www.ncbi.nlm.nih.gov/pubmed/37261930 http://dx.doi.org/10.1093/infdis/jiad197 |
Ejemplares similares
-
Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity
por: Abela, Irene A., et al.
Publicado: (2021) -
Recent HIV infections among newly diagnosed individuals living with HIV in rural Lesotho: Secondary data from the VIBRA cluster-randomized trial
por: Mohloanyane, Tsepang, et al.
Publicado: (2022) -
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response
por: Marconato, Maddalena, et al.
Publicado: (2022) -
The viral load monitoring cascade in a resource-limited setting: A
prospective multicentre cohort study after introduction of routine viral load
monitoring in rural Lesotho
por: Glass, Tracy Renee, et al.
Publicado: (2019) -
Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho
por: Amstutz, Alain, et al.
Publicado: (2020)